AI assistant
AMICUS THERAPEUTICS, INC. — Director's Dealing 2015
Jun 16, 2015
31523_dirs_2015-06-16_847b9262-b49f-4327-b373-7b9c1369ed9b.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: AMICUS THERAPEUTICS INC (FOLD)
CIK: 0001178879
Period of Report: 2015-06-15
Reporting Person: Yu Julie (VP Clinical Ops & Data Mgmt)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-06-15 | Common stock | S | 8195 | $14.17 | Disposed | 0 | Direct |
Footnotes
F1: The sales of shares of common stock were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 11, 2014.
F2: This price is the weighted average sale price for the transactions reported on this line. The prices for the transactions reported on this line range from $13.95 to $14.53. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.